Comments
Loading...

Salarius Pharmaceuticals

SLRXNASDAQ
Logo brought to you by Benzinga Data
$2.69
0.072.67%
At close: -
$2.73
0.041.35%
After Hours: Jan 17, 7:41 PM EDT
Decoy Therapeutics, Inc announced it will be merged with Salarius Pharmaceuticals (SLRX) on Monday, January 13, 2025

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Salarius Pharmaceuticals (SLRX)?

A

There have been no specific sales or earnings guidance reported for Salarius Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch